open access

Vol 17, No 4 (2010)
Original articles
Submitted: 2013-01-14
Published online: 2010-07-27
Get Citation

Forward stroke volume is predictor of perioperative course in patients with mitral regurgitation undergoing mitral valve replacement

Andrzej Gackowski, Anton Chrustowicz, Bogusław Kapelak, Tomasz Miszalski-Jamka, Nader El-Massri, Jerzy Sadowski
Cardiol J 2010;17(4):386-389.

open access

Vol 17, No 4 (2010)
Original articles
Submitted: 2013-01-14
Published online: 2010-07-27

Abstract

Background: Decreased left ventricle ejection fraction (LVEF) is a predictor of poor late outcome in patients with mitral regurgitation (MR). The relationship between pre-operative forward stroke volume (SV) and right heart parameters and perioperative outcome in patients with MR has been little studied.
Methods: Forty patients with severe organic MR, unsuitable for mitral valve repair, who underwent mitral valve replacement (MVR) were included in the study (50% men, average age 61 ± 9 years). Exclusion criteria were: aortic valve disease, coronary artery disease, rethoracotomy, stroke, infection or significant perioperative bleeding. Pre-operative detailed echocardiographic examination was performed. The end-point was post-operative prolonged intensive care unit (ICU) stay of more than three days because of the need for inotropic support.
Results: Pre-operative NYHA class was 2.6 ± 0.4, mean right ventricular end-diastolic diameter (RVEDD) was 28.7 ± 4 mm, TAPSE was 20 ± 4 mm, mean right ventricular systolic pressure (RVSP) was 38 ± 13 mm Hg, left ventricular end-systolic diameter was 43.5 ± 11 mm, left ventricular end-diastolic diameter was 60 ± 11 mm, left ventricular enddiastolic volume (Simpson) was 155 ± 47 mL, LVEF was 55 ± 11%, mean regurgitation fraction was 58% and forward SV (measured by Doppler) was 35 ± ± 11 mL. All patients survived the operation. Mean ICU stay was 3.2 ± 2.9 days (range 1-10 days), mean TISS-28 was 623 ± 293 and mean NEMS 151 ± 85. By univariate analysis, ICU stay was significantly longer in patients in higher pre-operative NYHA (p = 0.04), lower LVEF (p = 0.01), lower forward SV (p = 0.001) higher RF (p = 0.01), pre-operative right ventricular dilatation (p = 0.04), higher RVSP (p = 0.006) and right ventricular dysfunction (p = 0.04). By multivariate analysis, forward SV (p = 0.002, b = –0.45) and RVEDD (p = 0.02, b = 0.31) were independent predictors for prolonged ICU stay.
Conclusions: Pre-operative forward stroke volume and right ventricle size are predictors of the perioperative hemodynamic status in patients with mitral regurgitation undergoing MVR.
(Cardiol J 2010; 17, 4: 386-389)

Abstract

Background: Decreased left ventricle ejection fraction (LVEF) is a predictor of poor late outcome in patients with mitral regurgitation (MR). The relationship between pre-operative forward stroke volume (SV) and right heart parameters and perioperative outcome in patients with MR has been little studied.
Methods: Forty patients with severe organic MR, unsuitable for mitral valve repair, who underwent mitral valve replacement (MVR) were included in the study (50% men, average age 61 ± 9 years). Exclusion criteria were: aortic valve disease, coronary artery disease, rethoracotomy, stroke, infection or significant perioperative bleeding. Pre-operative detailed echocardiographic examination was performed. The end-point was post-operative prolonged intensive care unit (ICU) stay of more than three days because of the need for inotropic support.
Results: Pre-operative NYHA class was 2.6 ± 0.4, mean right ventricular end-diastolic diameter (RVEDD) was 28.7 ± 4 mm, TAPSE was 20 ± 4 mm, mean right ventricular systolic pressure (RVSP) was 38 ± 13 mm Hg, left ventricular end-systolic diameter was 43.5 ± 11 mm, left ventricular end-diastolic diameter was 60 ± 11 mm, left ventricular enddiastolic volume (Simpson) was 155 ± 47 mL, LVEF was 55 ± 11%, mean regurgitation fraction was 58% and forward SV (measured by Doppler) was 35 ± ± 11 mL. All patients survived the operation. Mean ICU stay was 3.2 ± 2.9 days (range 1-10 days), mean TISS-28 was 623 ± 293 and mean NEMS 151 ± 85. By univariate analysis, ICU stay was significantly longer in patients in higher pre-operative NYHA (p = 0.04), lower LVEF (p = 0.01), lower forward SV (p = 0.001) higher RF (p = 0.01), pre-operative right ventricular dilatation (p = 0.04), higher RVSP (p = 0.006) and right ventricular dysfunction (p = 0.04). By multivariate analysis, forward SV (p = 0.002, b = –0.45) and RVEDD (p = 0.02, b = 0.31) were independent predictors for prolonged ICU stay.
Conclusions: Pre-operative forward stroke volume and right ventricle size are predictors of the perioperative hemodynamic status in patients with mitral regurgitation undergoing MVR.
(Cardiol J 2010; 17, 4: 386-389)
Get Citation

Keywords

mitral regurgitation; stroke volume; right ventricle; mitral valve replacement; echocardiography; prognosis

About this article
Title

Forward stroke volume is predictor of perioperative course in patients with mitral regurgitation undergoing mitral valve replacement

Journal

Cardiology Journal

Issue

Vol 17, No 4 (2010)

Pages

386-389

Published online

2010-07-27

Page views

651

Article views/downloads

1301

Bibliographic record

Cardiol J 2010;17(4):386-389.

Keywords

mitral regurgitation
stroke volume
right ventricle
mitral valve replacement
echocardiography
prognosis

Authors

Andrzej Gackowski
Anton Chrustowicz
Bogusław Kapelak
Tomasz Miszalski-Jamka
Nader El-Massri
Jerzy Sadowski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl